Second transplantation after kidney graft loss in primary hyperoxaluria type 2: a pedigree study and mutation analysis
Our findings suggest that treatment strategies for the long-term prevention of oxalate nephropathy should be developed for patients with PH2 receiving isolated kidney transplantation. Moreover, the pathogenicity of the compound heterozygous <i>GRHPR</i> mutations p.G160E/p.P203Rfs*7 was also validated.
Authors
- Yun Miao (ORCID: https://orcid.org/0000-0003-3592-4695)
- Yingchun Zheng (ORCID: https://orcid.org/0000-0001-7902-6307)
- Fu Xiong
- Renfei Xia (ORCID: https://orcid.org/0009-0002-2400-2513)
- Wenfeng Deng
- Jialiang Hui (ORCID: https://orcid.org/0000-0002-9879-9388)
- Jian Xu (ORCID: https://orcid.org/0000-0001-7635-9253)
- Wenli Zeng (ORCID: https://orcid.org/0000-0003-3256-1817)
- Yuchen Wang (ORCID: https://orcid.org/0000-0003-3253-5117)
- Mingming Zhang (ORCID: https://orcid.org/0000-0001-6907-4049)
- Jia Luo (ORCID: https://orcid.org/0000-0003-4936-7586)
- Yiling Fang (ORCID: https://orcid.org/0000-0002-1471-0287)
- Yushi Peng
Institutions
- Nanfang Hospital (CN)
- Guangzhou Women and Children Medical Center (CN)
- Southern Medical University (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Renal Failure
- Published
- 2024-10-24
- DOI
- https://doi.org/10.1080/0886022x.2024.2417743
- Citations
- 1
- Primary Topic
- Kidney Stones and Urolithiasis Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.42
Funders
- National Natural Science Foundation of China